Safety and Efficacy of a Progressively Prolonged Maintenance Interval of Venom Immunotherapy

Int Arch Allergy Immunol. 2018;176(1):39-43. doi: 10.1159/000488143. Epub 2018 Apr 12.

Abstract

Background: The long-term protection provided by venom immunotherapy (VIT) is related to the dose administered and to its long duration; the latter, however, becomes inconvenient for patients in countries like Greece, with many islanders or inhabitants of distant mountainous areas. Maintenance interval prolongation reduces the number of office visits - saving time and money - and as a consequence contributes to the patients' compliance. The aim of this prospective study was to evaluate the safety and efficacy of VIT on a progressively prolonged maintenance interval (PPMI).

Method: 450 venom-allergic patients were reviewed for participation in our study; all of them were initially treated with a modified rush or an ultrarush protocol using freshly reconstituted, pure venoms. Upon reaching the maintenance dose, the VIT interval was scheduled to be gradually prolonged - by 1 week each time - aiming at a maximal interval of 26 weeks.

Results: 267/450 patients consented to participate in our VIT PPMI protocol: 98 were treated with vespid(s) venom, 142 with honeybee venom, and 27 with both. The mean duration of patient follow-up was 9.1 ± 4.2 years. The majority of systemic reactions due to VIT injections occurred up to the 8-weeks PPMI; few additional reactions were documented in a small fraction (2.9%) of our patient population beyond 9 weeks and up to 16 weeks; all were caused by honeybee VIT. No reactions were observed during VIT administration at the 26-week interval. Ninety-six patients reported 204 field sting occurrences by the culprit insect. Ten systemic reactions (8 mild and 2 moderate in severity) were registered between the 9- and 18-week PPMI; the honeybee was the culprit insect in all cases. 108 field stings by the offending insect were sustained beyond the 20- and up to the 26-week PPMI; there were no reactions at all.

Conclusions: Progressively prolonging the VIT maintenance interval up to 26 weeks appears to be safe and efficacious.

Keywords: Immunotherapy; Maintenance interval; Prolonged interval; Venom.

Publication types

  • Clinical Trial

MeSH terms

  • Animals
  • Bee Venoms / administration & dosage*
  • Bee Venoms / immunology
  • Bees / immunology*
  • Desensitization, Immunologic / methods*
  • Follow-Up Studies
  • Greece
  • Humans
  • Hypersensitivity, Immediate / etiology
  • Hypersensitivity, Immediate / therapy*
  • Insect Bites and Stings / immunology*
  • Patient Compliance
  • Prospective Studies
  • Time Factors
  • Treatment Outcome
  • Wasp Venoms / administration & dosage*
  • Wasp Venoms / immunology
  • Wasps / immunology*

Substances

  • Bee Venoms
  • Wasp Venoms